Manufacturer record
Firstmed Therapeutics Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Firstmed Therapeutics Pvt Ltd were declared Not of Standard Quality between April 2025 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: FLRL-0004, Rabeprazole Sodium Tablets IP (exp Mar 2027). DTL, Puducherry (state lab) found it not of standard quality: Incorrect labelling. Listed in the August 2025 alert.
Records by type
4 records linked to Firstmed Therapeutics Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium Tablets IP | Batch FLRL-0004Mfg Apr 2025 · Exp Mar 2027 | Incorrect labellingLabelling | DTL, PuducherryState lab | Aug 2025 |
| Paracetamol And Aceclofenac Tablets | Batch FAPS-2057Mfg Feb 2025 · Exp Jan 2027 | Incorrect labellingLabelling | DTL, PuducherryState lab | Aug 2025 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP(Moncube LC) | Batch FDMC-588Mfg Jul 2024 · Exp Jun 2026 | For the received sample Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP (Moncube LC),Presence of Spots was observed which should not be presentOther | State Lab PuducherryState lab | Apr 2025 |
| Glypro 1 (Glimepiride Tablets IP) 1mg | Batch FGYO-1626Mfg Dec 2024 · Exp Nov 2026 | Sample does not conform to IP specification for Glimepiride Tablets with respect to the content of GlimepirideOther | DTL MaduraiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.